Clinical Trial Update: Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety and tolerability of multiple ascending doses of REGN1500 in metabolic disorders; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Disorders

Drugs mentioned

• REGN1500

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Metabolic Disorders | Phase 1 | Status: COMPLETED